Clinical Trials Browser

Recruiting × NETWORK × Carcinoma, Hepatocellular × Clear all

NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT06880523 2026-04-14

SLIDE-HCC

Phase 2 Recruiting

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05935189 2023-07-07

TIR-HCC

Recruiting

500 enrolled

Gastrointestinal

Carcinoma, Hepatocellular